WHO-GMP-ISO Certified Manufacturer Verified Company Quick Response · Fast Dispatch PCD Pharma Franchise

Ovireg-21 Days Tablets

● In Stock Rx Required
Gynecology Hormone Treatment Tablet

Ovireg-21 Days Tablets contain Desogestrel BP 0.15 mg & Ethinylestradiol IP 0.03 mg, a combined oral contraceptive pill. Available from Pharmakon Lifesciences, Karnal, for PCD franchise and third-party manufacturing.

Dosage Form Tablet
Composition Desogestrel BP 0.15 mg & Ethinylestradiol IP 0.03 mg
Packing 10x1x21 Blister (Mono Carton)
MRP On Request
Available For: ✓ PCD Pharma Franchise ✓ Third-Party Mfg.
Interested in this product? < 24 hours
WhatsApp
Verified Manufacturer

Product Description

Ovireg-21 Days Tablets contain Desogestrel BP 0.15 mg & Ethinylestradiol IP 0.03 mg, a combined oral contraceptive pill. Available from Pharmakon Lifesciences, Karnal, for PCD franchise and third-party manufacturing.

Indications

Contraception
Cycle regulation (as prescribed)

Dosage

As directed by the physician.

Side Effects

Nausea, breast tenderness, headache, spotting or mood changes may occur. Use only under the supervision of a gynaecologist.

Storage Instructions

Store in a cool, dry place below 30°C, protected from light and moisture.
Keep out of the reach of children.

Availability

Ovireg-21 Days Tablets is available for PCD Pharma Franchise distribution and Third-Party Contract Manufacturing across India. Reach out to the manufacturer for pricing, MOQ and territory details.

Pharmaceutical Specifications

Product NameOvireg-21 Days Tablets
Dosage FormTablet
CompositionDesogestrel BP 0.15 mg & Ethinylestradiol IP 0.03 mg
StrengthN/A
Packing10x1x21 Blister (Mono Carton)
MRPOn Request
PrescriptionRx Required
Manufactured byPharmakon Lifesciences, Karnal
Delivery Time15–25 working days
CertificationsISO 9001:2015 · WHO-GMP · Verified Company

Company Information